Testing effectiveness (Phase 2)Active Not RecruitingNCT00877500
What this trial is testing
Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy
Who this might be right for
Bilateral Breast CarcinomaHER2/Neu NegativeInvasive Breast Carcinoma
M.D. Anderson Cancer Center 116